The store will not work correctly when cookies are disabled.
(3-fluorophenyl)(2-hydroxy-4,6-dimethoxy-3-(pyrrolidin-1-ylmethyl)phenyl)methanone
ID: ALA1092123
PubChem CID: 46884423
Max Phase: Preclinical
Molecular Formula: C20H22FNO4
Molecular Weight: 359.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2cccc(F)c2)c(O)c1CN1CCCC1
Standard InChI: InChI=1S/C20H22FNO4/c1-25-16-11-17(26-2)18(19(23)13-6-5-7-14(21)10-13)20(24)15(16)12-22-8-3-4-9-22/h5-7,10-11,24H,3-4,8-9,12H2,1-2H3
Standard InChI Key: WDKVOQDTNUONSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.4652 -23.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4641 -24.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1789 -24.8819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8953 -24.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8925 -23.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1771 -23.2289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7493 -24.8809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0351 -24.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1746 -22.4039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8879 -21.9892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6105 -24.8799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6054 -23.2228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3214 -23.6326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6023 -22.3978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3212 -24.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0363 -24.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7502 -24.4497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7445 -23.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0287 -23.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1787 -25.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4641 -26.1192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7111 -25.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1589 -26.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5712 -27.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3782 -26.9429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4559 -23.2028 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
3 20 1 0
9 10 1 0
20 21 1 0
21 22 1 0
2 3 1 0
4 11 1 0
5 6 2 0
5 12 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
6 1 1 0
18 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.40 | Molecular Weight (Monoisotopic): 359.1533 | AlogP: 3.38 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.00 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.00 | CX Basic pKa: 7.97 | CX LogP: 2.76 | CX LogD: 2.73 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: -0.43 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |